89bio Inc (NAS:ETNB)
$ 8.855 0.385 (4.55%) Market Cap: 937.83 Mil Enterprise Value: 433.80 Mil PE Ratio: 0 PB Ratio: 1.73 GF Score: 36/100

89Bio Inc at H.C. Wainwright & Co LLC 7th Annual NASH Investor Conference (Virtual) Transcript

Oct 24, 2023 / 03:30PM GMT
Release Date Price: $7.02 (+5.41%)
Ed Arce
H.C. Wainwright & Co., LLC - Analyst

Hello, and welcome again to the seventh annual H.C. Wainwright NASH Investor Conference. My name is Ed Arce, and I'm one of the senior biotech analysts here at HCW. Our next presenting company is 89bio. I'm very pleased to have with us representing the company is CEO Rohan Palekar. Rohan, it's great to see you. Please take it away.

Rohan Palekar
89bio, Inc. - CEO

Hey, Ed, thanks for having us at the meeting, and look forward to the discussion. So appreciate it.

Questions & Answers

Ed Arce
H.C. Wainwright & Co., LLC - Analyst

Right. So let's start from where a lot of the attention is right now in this space, given the readout from two weeks ago with Akero -- the Symmetry readout. Were there any surprises for you there with that result, especially given you have the same mechanism as their drug?

Rohan Palekar
89bio, Inc. - CEO

Yeah. And when we look at the Symmetry data, we look at the totality of the data.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot